Argenx Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), IGC Pharma (IGC) and Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
Jefferies Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $598
Baird Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $515
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Truist Financial Keeps Their Buy Rating on Argenx Se (ARGX)
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Boston Scientific (BSX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $533 to $585
Argenx Price Target Raised to $547.00/Share From $543.00 by Wells Fargo
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $497 to $598
Argenx Analyst Ratings
Argenx Se (ARGX) Gets a Hold From UBS
Buy Rating Affirmed: Argenx Se's Financial Success and Clinical Promise
JMP Securities Sticks to Their Buy Rating for Argenx Se (ARGX)
Wells Fargo Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $547
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Argenx Se (ARGX)
Oppenheimer Upgrades Argenx to Outperform, Cites Vyvgart Hytrulo
Argenx Analyst Ratings
Oppenheimer Upgrades Argenx SE to Outperform From Perform, $546 Price Target
Oppenheimer Upgrades Argenx SE(ARGX.US) to Buy Rating, Announces Target Price $546